Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

ConditionAdvanced Breast Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorWenjin Yin

About this trial

To compare the efficacy and safety of capecitabine and cyclophosphamide (XC) versus physician's choice as maintenance therapy for patients with advanced breast cancer who achieved disease control after salvage treatment.

Eligibility criteria

Qualifiers

Female, age≥18 years old

ECOG≤2

Pathologically confirmed primary breast cancer, with pathologically or radiologically confirmed recurrent or metastatic lesions

HR+/HER2+ or HR-/HER2+ or HR-/HER2-

Disqualifiers

during pregnancy and lactation

Patients with central nervous system metastasis

Trial design

Treatments tested in this trial

Treatment groups

86 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Wenjin Yin

Lead sponsor

RenJi Hospital

Sponsor institution

Source ClinicalTrials.gov